Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-002208-14Phase 4Terminated
Phase 4 trial of amiodarone in Atrial fibrillation (AFib), sponsored by Cardiff and Vale University Health Board. Primary endpoints: Optimal duration of amiodarone therapy and Safety and side effect profile. Started Jun 2005; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-002208-14.